Silence Therapeutics Reports Second Quarter 2023 Results
Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines,... -Today at 07:03 am- MarketScreener
Craig Tooman Hansoh Pharma Program Updates Mallinckrodt Pharmaceuticals Exchange Commission On Silence Therapeutics
Source: marketscreener.com